Exercise may shield MS brains from damage, small trial hopes to show
NCT ID NCT07520812
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will test whether a 12-week progressive resistance training program can improve brain health in people with relapsing-remitting multiple sclerosis. Researchers will measure brain volume and a nerve damage marker in the blood. The trial involves 26 participants and aims to see if exercise can be a helpful addition to standard care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- progressive resistance training (exercise program)
- What this could lead to
- If successful, this could show that regular exercise helps protect the brain in people with multiple sclerosis, pointing toward a simple, drug-free way to manage the disease.
- What could go wrong
- This is a very small, early-stage trial with only 26 participants, so results may not apply to everyone. It is also not designed to prove exercise treats MS, only to measure changes in certain biomarkers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXERCISE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fırat University
Elâzığ, 23100, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we decode the different types of pain in multiple sclerosis?
- Can a blood pressure pill slow MS disability?
- Water workouts could be the key to back pain relief
- Hidden MS progression: can brain scans and blood tests predict it?
- Can Brain-Training apps fix sleep in MS?
- Can an Iron-Based dye reveal hidden inflammation in progressive MS?